Peter Rahal, Co-founder and CEO of RXBar, says the company was founded on the transparency of its ingredients, and that purpose led to a $600 million buyout from Kellogg.
Rahal explains why ever ingredient in every product is in bold letters on the front of the package. When the company started out, "people would be like ‘well what is it?'” So they made the answer easy to find.
Rahal discusses RXBAR's $600 million sale to Kellogg, and the future direction of the company, where he will remain as CEO. We talk about the whirlwind the company's evolution has been, given that it was founded in 2013, when Rahal and his co-founder were both broke. Then we look ahead to what's next for the company after the Kellogg buyout.
Voyager Technologies CEO Dylan Taylor discusses the booming commercial space race, NASA partnerships, defense tech, and building the future beyond Earth.
Inflation is outrunning growth, squeezing consumers and raising fear of a summer slowdown as high rates and sticky prices test spending and markets today now.
TIME's editorial director Emma Barker unpacks the 2026 100 Most Influential Companies list, spotlighting trends, AI impact, surprises, and leadership shifts.
From dire wolves to new species targets, scientists at Colossal Biosciences are using gene editing to revive extinction and reshape biodiversity as we know it.
